Marc Lemonnier is the founder of Antabio. Antabio has raised $55M in total funding. Latest round: Series B. Based in Labèģı, France.
Marc Lemonnier is the Founding CEO and co-founder of Antabio, a biopharmaceutical company specializing in treatments for drug-resistant infections. He established Antabio in 2009 and has guided the company through several funding stages, including a significant Series B round in late 2023. Lemonnier is also an Officer at BEAM Alliance, an organization focused on fighting antimicrobial resistance.
Full founder directory · Investor directory · Company funding database · Fundraising library